Spotlight on frovatriptan: a review of its efficacy in the treatment of migraine

Migraine is a common neurovascular disorder, affecting millions of people worldwide. Current guidelines recommend triptans as first-line treatment for moderate-to-severe migraine attacks. Frovatriptan is a second-generation triptan with a longer terminal elimination half-life in blood than other tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Allais, Gianni, Benedetto, Chiara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055118/
https://www.ncbi.nlm.nih.gov/pubmed/27757013
http://dx.doi.org/10.2147/DDDT.S105932

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055118/
https://www.ncbi.nlm.nih.gov/pubmed/27757013
http://dx.doi.org/10.2147/DDDT.S105932

Ejemplares similares